NVO vs. MSTR
NVO (Novo Nordisk A/S) and MSTR (Strategy Inc) are both stocks. NVO operates in Drug Manufacturers - General (Healthcare), while MSTR operates in Software - Application (Technology). Over the past 10 years, NVO returned 8.18%/yr vs 17.94%/yr for MSTR. At a 0.18 correlation, their price movements are largely independent.
Performance
NVO vs. MSTR - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, NVO achieves a 0.91% return, which is significantly higher than MSTR's -35.62% return. Over the past 10 years, NVO has underperformed MSTR with an annualized return of 8.18%, while MSTR has yielded a comparatively higher 17.94% annualized return.
NVO
- 1D
- -1.41%
- 1M
- 14.86%
- 6M
- -17.63%
- YTD
- 0.91%
- 1Y
- -19.26%
- 3Y*
- -13.51%
- 5Y*
- 4.43%
- 10Y*
- 8.18%
- ALL TIME*
- 14.52%
MSTR
- 1D
- 3.13%
- 1M
- -13.07%
- 6M
- -43.69%
- YTD
- -35.62%
- 1Y
- -76.89%
- 3Y*
- 30.85%
- 5Y*
- 11.92%
- 10Y*
- 17.94%
- ALL TIME*
- 9.32%
NVO vs. MSTR - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | 0.91% | -39.22% | -15.93% | 54.84% | 22.66% | 63.52% | 23.33% | 28.70% | -12.98% | 52.92% |
MSTR Strategy Inc | -35.62% | -47.53% | 358.54% | 346.15% | -74.00% | 40.13% | 172.42% | 11.65% | -2.70% | -33.49% |
Correlation
The correlation between NVO and MSTR is 0.24, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.24 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.16 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.18 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Jun 11, 1998 | 0.18 |
Fundamentals
NVO:
$220.46B
MSTR:
$29.06B
NVO:
DKK 27.42
MSTR:
-$39.78
NVO:
4.40
MSTR:
61.95
NVO:
7.11
MSTR:
0.89
NVO:
DKK 327.80B
MSTR:
$490.47M
NVO:
DKK 268.30B
MSTR:
$334.08M
NVO:
DKK 181.54B
MSTR:
$466.93M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
NVO vs. MSTR — Risk / Return Rank
NVO
MSTR
NVO vs. MSTR - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Novo Nordisk A/S (NVO) and Strategy Inc (MSTR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| NVO | MSTR | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.66 | ||
| Sortino ratioReturn per unit of downside risk | +2.04 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 0.77 | +0.20 |
| Calmar ratioReturn relative to maximum drawdown | -0.39 | -0.95 | +0.56 |
| Martin ratioReturn relative to average drawdown | -0.61 | -1.38 | +0.77 |
Loading charts...
Drawdowns
NVO vs. MSTR - Drawdown Comparison
The maximum NVO drawdown since its inception was -74.70%, smaller than the maximum MSTR drawdown of -99.86%. Use the drawdown chart below to compare losses from any high point for NVO and MSTR.
Loading charts...
Drawdown Indicators
| NVO | MSTR | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -74.70% | -99.86% | +25.16% |
Max Drawdown (1Y)Largest decline over 1 year | -49.17% | -80.70% | +31.53% |
Max Drawdown (3Y)Largest decline over 3 years | -74.70% | -82.63% | +7.93% |
Max Drawdown (5Y)Largest decline over 5 years | -74.70% | -84.11% | +9.41% |
Max Drawdown (10Y)Largest decline over 10 years | -74.70% | -89.27% | +14.57% |
Current DrawdownCurrent decline from peak | -63.95% | -79.36% | +15.41% |
Average DrawdownAverage peak-to-trough decline | -17.89% | -86.43% | +68.54% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 31.75% | 55.87% | -24.12% |
Volatility
NVO vs. MSTR - Volatility Comparison
The current volatility for Novo Nordisk A/S (NVO) is 9.48%, while Strategy Inc (MSTR) has a volatility of 25.51%. This indicates that NVO experiences smaller price fluctuations and is considered to be less risky than MSTR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| NVO | MSTR | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.48% | 25.51% | -16.03% |
Volatility (6M)Calculated over the trailing 6-month period | 37.43% | 60.54% | -23.11% |
Volatility (1Y)Calculated over the trailing 1-year period | 51.79% | 74.28% | -22.49% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 38.58% | 90.77% | -52.19% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 32.63% | 74.27% | -41.64% |
Dividends
NVO vs. MSTR - Dividend Comparison
NVO's dividend yield for the trailing twelve months is around 3.63%, while MSTR has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
MSTR Strategy Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
NVO Novo Nordisk A/S | 3.63% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
Financials
NVO vs. MSTR - Financials Comparison
This section allows you to compare key financial metrics between Novo Nordisk A/S and Strategy Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
NVO and MSTR have a correlation of 0.24, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MSTR has higher volatility (25.51%) compared to NVO (9.48%). In terms of maximum drawdown, NVO dropped -74.70% vs MSTR's -99.86%.
NVO currently has the higher Sharpe Ratio (-0.37 vs -1.04), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for NVO and MSTR
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer